Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

Haematologica 2011 Mar 25;96(3):454-8. Epub 2010 Nov 25.

Division of Hematology, Department of Hematology Oncology, University of Pavia Medical School and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Within a cohort of 1,915 consecutive patients with myeloproliferative neoplasm followed for a median time of 5.2 years (range 0-33.3), we investigated the occurrence of lymphoid neoplasm with the aim of defining this risk and to investigate the role of genetic predisposing factors. We identified 22 patients with myeloproliferative neoplasm who developed lymphoid neoplasm over their lifetime. We found that the risk of developing lymphoid neoplasm was 2.79-fold higher (95% CI, 1.80-4.33; P<0.001) than that of the general Italian population. A tag SNP surrogate for JAK2 GGCC haplotype was used to clarify a potential correlation between lymphoid-myeloid neoplasm occurrence and this genetic predisposing factor. As we did not find any difference in GGCC haplotype frequency between patients with both myeloid and lymphoid neoplasm and patients with myeloid neoplasm, JAK2 GGCC haplotype should not be considered a genetic predisposing factor. No difference in familial clustering was observed between the two groups.

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.033779DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046278PMC
March 2011
18 Reads

Publication Analysis

Top Keywords

lymphoid neoplasm
16
myeloproliferative neoplasm
12
patients myeloproliferative
12
neoplasm
7
predisposing factors
4
risk investigate
4
investigate role
4
genetic predisposing
4
role genetic
4
aim defining
4
0-333 investigated
4
range 0-333
4
investigated occurrence
4
neoplasm aim
4
factors identified
4
defining risk
4
developed lymphoid
4
neoplasm 279-fold
4
279-fold higher
4
higher 95%
4

Similar Publications